Printer Friendly

Food Intake and Core Body Temperature of Pups and Adults in a db Mouse Line Deficient in the Long Form of the Leptin Receptor without Misty Mutation.

1. Introduction

Leptin and the leptin receptor (Lepr) are important for physiological and pathological states related to body weight (BW) regulation in humans and rodents [1-5]. To date, many studies investigating leptin and Lepr have revealed important roles in energy balance, particularly food intake (FI) and body temperature (BT) regulation in adults [6, 7]. In addition, leptin and Lepr may be involved in neuronal development at infancy [8, 9]. To our knowledge, the physiological and pathological roles of leptin signaling in adults have been well characterized, but the roles of leptin signaling in pups remain to be elucidated.

To reveal the role of leptin and Lepr in vivo, two mutant mouse strains with ligand (ob/ob mice) or receptor deficiency (db/db mice) have been widely used as obesity and type 2 diabetes animal models, respectively [10]. In ob/ob mice, the effects of leptin administration were examined to elucidate the role of leptin in appetite and thermogenesis [6, 11]. Additionally, in db/db mice, the genetically induced rescue of Lepr was assessed to elucidate the role of leptin signaling in the hypothalamus and sympathetic nerves [12-14]. Leptin signaling is primarily mediated through orexigenic peptides, such as neuropeptide Y (NPY) and agouti-related peptide (AgRP), and anorexigenic peptides, such as proopiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART), in the arcuate nucleus of the hypothalamus [1]. Specifically, leptin signaling suppresses orexigenic peptide expression and increases anorexigenic peptide expression. In addition, uncoupling proteins in brown adipose tissues (BAT) were enhanced by leptin signaling through the sympathetic nervous system [6]. However, postnatal ob/ob and db/db mice displayed similar but slightly heavier BWs to their respective controls including heterozygotes and wild-type (WT) mice [15-18]. Leptin administration experiments using WT mice revealed that leptin did not influence mRNA levels of hypothalamic orexigenic and anorexigenic peptide in pups [19]. Physiologically, similar to leptin administration, increased plasma leptin concentrations in pups is termed the leptin surge [20]. In a leptin administration study, there were different results in orexigenic and anorexigenic peptide genes' expression in pups and adults, suggesting that leptin signaling may differ between pups and adults [19, 20].

db/db mice might be useful to examine the age-dependent influence of Lepr deficiency [21]. However, db/ db mice under the BKS.Cg background are generally identified by coat color because of proteins coded by the dedicator of cytokinesis 7 (Dock7) gene, which is near the Lepr gene [22, 23]. Specifically, mice with a homozygous db gene express the wild-type Dock7 gene, leading to obesity and black coat color. Thus, mice with a wild-type Lepr gene display a homozygous mutation in the Dock 7 gene, named misty (m/m), leading to a lean body type and grey coat color [24]. Recently, a Dock7 knockout mouse study indicated the Dock7 product involved in the development of neuronal cells related to the sympathetic nervous system, in addition to BW regulation [25, 26]. As a result, m/m mice have lower BWs than WT mice. Therefore, to examine the lack of Lepr signaling on BT and FI regulation in an age-dependent manner, especially in pups, a line of db mice without the influence of the misty gene should be established.

Using a db mouse line without the influence of misty, we examined FI and BT in pups and adults. In addition, the age-dependent expression of orexigenic and anorexigenic genes in the hypothalamus and uncoupling protein 1 (Ucp1) in the BAT was examined. Furthermore, thyroid function, which is associated with FI and BT regulation, was surveyed. In the present study, the roles of the long form of Lepr, which is specifically deficient in db/db mice, in the age-dependent regulation of FI and BT were elucidated.

2. Materials and Methods

2.1. Animals. All mice were maintained at a constant room temperature of 22 [+ or -] 2[degrees]C, with a 12 h light cycle (07:00-19:00 h) and free access to water and standard chow (14.4 kJ/g, CE-2; CLEA Japan, Tokyo, Japan). Briefly, we generated a mouse line carrying the db gene, a mutation in the Lepr gene, without a mutation in the Dock7 gene (misty). First, we purchased heterozygote male mice (BKS.Cg-[Dock7.sup.M][Lepr.sup.db]/[Dock7.sup.m][Lepr.sup.+]; M db/m+) that had a black coat color and lean body type (Charles River, Kanagawa, Japan; and CLEA Japan, Tokyo, Japan). As displayed in Table 1, some mice were M db/M+, possibly because of natural recombination during breeding at the companies. A male M db/M+ mouse was mated with female M db/m+ mice, producing M db/M db, M db/m+, M db/M+, and M+/m+. The mating for the experiments was permitted by the company (Charles River). From the genotyping results of the pups, we obtained a pair of Lepr gene heterozygotes, who had the wild-type Dock7 gene (M db/M+). Male and female M db/M+ mice were mated to obtain WT (M+/M+: +/+), heterozygous (M db/M+: db/+), and homozygous (M db/M db: db/db) mice. We chose a colony with 5-8 litters and genotyped the mice (+/+, db/+, and db/db) at 1 week of age. Mice BWs were measured weekly from 1 to 8 weeks of age. Mice were individually recognized by black pen markings on the surface of their hand and foot. At 3 weeks of age, the mice were removed from their dams, separated by sex, and placed into a cage with littermates of the same sex. At 4 weeks of age, mice were separated and then kept individually in one cage. Male +/+ mice and db/db littermates at 2 and 8 weeks of age were further examined as pups and adults, respectively. db/db mice at 8 weeks of age were designated as adults, although this is younger than generally defined, because older mice display a loss of hyperinsulinemic conditions [21, 22]. Mice were anesthetized with pentobarbital (100 mg/kg) after 3 h fasting to prevent influences by overfasting at infancy. Accordingly, mice at 8 weeks of age were treated after 3 h fasting. Blood was collected from the heart with a syringe containing EDTA (final concentration, 4mM) and centrifuged at 2000 xg for 5 min to separate plasma. Mice were then euthanized by cervical dislocation, and the brain, heart, liver, white adipose tissue (WAT, fat surrounding epididymis), and BAT were removed, blotted, weighed, and frozen immediately in liquid nitrogen. The hypothalamic block was separated from the brain [27]. The plasma and frozen organs were stored at -80[degrees]C until analysis.

All animal experiments and procedures used in the present study were approved by the Ethics Committee for Animal Experimentation at Kagoshima University (MD15004, 16035, and 16087), which is standardized to the Japanese national guidelines for animal experiments. Additionally, the principles of laboratory animal care were followed.

2.2. Genotyping for the Lepr and Dock7 Genes. Previously, db, a mutation in the Lepr gene, was obtained using the PCR method with mismatched primers [28, 29]. In the present study, for increased reliability, the PCR method without mismatched primers was established as follows. DNA was obtained from the tail or ear tissue from mice at 1 week of age, as described above, using the KAPA Express Extract DNA Extraction Kit (KAPA Biosystems, MA, USA). The DNA extracted was used as a template for the genes identified.

The Lepr gene was amplified with forward and reverse primers (Supplementary Table 1) by PCR. The PCR product was digested with Hpy166II restriction enzyme (New England Biolabs Japan Inc.). The PCR products digested were analyzed by agarose gel (Kanto HC, Kanto Chemical Co., Inc., Tokyo, Japan) for identification of the three genotypes (+/+, db/+, and db/db). The Dock7 gene was amplified with one forward and two reverse primers (Supplementary Table 1). The PCR products were analyzed by agarose gel, and Dock7 genotyping (M/M, m/M, and m/m) was performed.

2.3. Food and Milk Intake Measurements. For adults, the weight of the diet was measured at 9:00 h. FI was then calculated as the difference in diet weight over 4 consecutive days. To measure milk intake of mice at 2 weeks of age, dams were separated from pups for 3 h. The pups were weighed 3 h after separation and again after 1 hour of suckling. Body weight gain during 1 h of suckling was utilized to estimate milk intake [30].

2.4. Core Body Temperature Measurements. Core BT was measured with a high traceable thermometer D642 (Tateyama Kagaku Group, Toyama, Japan). The thermocouple electrode was introduced 15mm into the rectum of the animals.

2.5. Biochemical Parameters. Plasma glucose and triglyceride (TG) levels were measured with a commercial kit (Wako, Osaka, Japan). Plasma insulin, leptin, and corticosterone concentrations were measured with the respective ELISA kits (Morinaga Institute of Biological Science Inc., Kanagawa, Japan; R&D Systems, Minneapolis, MN, USA; Enzo Life Science Inc., PA, USA). Plasma hormones related to thyroid function, such as triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone (TSH), were measured by ELISA (Cusabio, Biotech Co., MD, USA).

2.6. Gene Expression. RNA from the hypothalamus and BAT was extracted using a Trizol reagent (Ambion, Carlsbad, CA, USA) following the manufacturer's instruction. Isolated RNA was treated with DNase (Ambion, Carlsbad, CA, USA) to remove genomic contamination. First-strand cDNA was synthesized using 5 [micro]g total RNA with oligo[(dT).sub.20] (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instruction. Gene expression was determined by quantitative RT-PCR with gene-specific primers using the SYBR Green Master Mix (Roche, Mannheim, Germany) on a TAKARA detection system TP800 (TAKARA, Shiga, Japan). Relative mRNA levels were determined by the [2.sup.-[DELTA][DELTA]CT] method, with Gapdh as a reference gene. Primer sequences are provided in Supplementary Table 1.

2.7. Statistical Analyses. Values are presented as the mean [+ or -] standard error (SE). Significant differences between groups in Figure 1 were identified using two-way (repeated measurement) ANOVA (SPSS, Version 23.0). Significant differences between groups in Tables 2 and 3 were identified using two-way (factorial) ANOVA, followed by the Tukey-Kramer method as a multiple comparison. For the statistical analysis in Figure 2 and in a part of Tables 2 and 3, paired and unpaired Student's t-tests were used as appropriate. P < 0.05 was considered significant.

3. Results

3.1. Establishment of a Mouse Line Carrying [Lepr.sup.db] with Wild-Type Dock7. We classified mice with a black coat color and lean body type from the two companies as heterozygotes (expected genotype, M db/m+) (Table 1). Because of natural recombination during breeding at the companies, we obtained a male mouse carrying db with wild-type Dock7 (M db/M+). By further mating, we then generated mice carrying db without the Dock7 mutation. For the experiments, we produced mice by cross mating in the line.

3.2. Body Weight Differences between +/+ and db/db Mice. Figure 1 illustrates the changes in BW in wild-type mice (WT: [Lepr.sup.+]/[Lepr.sup.+]) and homozygous mutants (db/db: [Lepr.sup.db]/[Lepr.sup.db]) in male (a) and female (b) mice fed with a regular chow diet after weaning at 3 weeks of age. There were no significant differences in BW between male and female WT and db/db mice for the initial 6 and 5 weeks after birth by two-way (repeated measurement) ANOVA. Both male and female db/db mice displayed significantly higher BWs than WT mice in 7 and 6 weeks of age after birth, respectively.

3.3. Milk and Food Intake. As displayed in Table 2, both sexes of WT and db/db mice displayed a similar BW change, indicating that mice ingested a similar amount of milk during the 1 h suckling period at 2 weeks of age. Seven WT and 7 db/db male mice were obtained from the same four mothers. The mean litter size was 7.7 [+ or -] 1.1 and 7.9 [+ or -] 1.2, indicating no significant difference. Furthermore, 5 WT and 5 db/db female mice were obtained from the same three mothers and one different mother. The mean litter size was 7.6 [+ or -] 1.1 and 7.0 [+ or -] 1.0, indicating no significant difference. Therefore, the milk availability between genotypes was not influenced by the litter size. However, both sexes of db/db mice displayed higher FI than WT mice at 8 weeks of age.

3.4. Organ Weights. Organ weights, including the brain, heart, liver, WAT, and BAT, were measured in male mice (Table 2). There was a significance in the interaction between age and genotype in the brain, liver, and WAT. With a multiple comparison, the respective weight of organs such as the brain, liver, and WAT of db/db and WT mice was similar at 2 weeks of age and significantly different at 8 weeks of age. The heart weight was significantly different between mice at 2 and 8 weeks of age. In BAT, db/db mice displayed significantly higher weights than WT mice, and mice at 8 weeks of age displayed higher weights than mice at 2 weeks of age.

3.5. Biochemical Parameters. Only males were examined. There was a significance in the interaction between age and genotype in glucose, insulin, leptin, and corticosterone. With a multiple comparison, the values in glucose, insulin, and corticosterone of db/db and WT mice were similar at 2 weeks of age and significantly different at 8 weeks of age. In leptin, db/db mice at both ages displayed a significantly higher value than WT mice at both ages, respectively. Additionally, plasma TG levels were comparable between the two genotypes at 2 and 8 weeks of age, although mice at 8 weeks of age displayed a significantly higher value than mice at 2 weeks of age. For hormones related to thyroid function, db/db mice showed significantly lower T4 but similar T3 and TSH levels in plasma compared with WT mice.

3.6. Core Body Temperature. Core BT at 8:00 and 20:00 h was measured in both sexes of WT and db/db mice at 2 and 8 weeks of age (Table 3). There was not a significance in the interaction between age and genotype in BT at 8:00 and 20:00 h, respectively. Both sexes of db/db mice displayed significantly lower BTs than WT mice at 8:00 and 20:00 h, respectively. Both sexes of mice at 8 weeks of age displayed significantly higher BTs than mice at 2 weeks of age, except BT at 8:00 h of female mice between ages. Both sexes of WT and db/db mice at 8 weeks of age had significantly higher BTs at 20:00 h than those of the corresponding mice at 8:00 h. Additionally, both sexes of WT and db/db mice at 2 weeks of age had significantly higher BTs at 20:00 h than those of the corresponding mice at 8:00 h, except male WT mice at 2 weeks of age.

3.7. Expression of Genes Related to Leptin Signaling for FI and Thermogenesis Regulation. Only males were examined. To understand the mechanism underlying the role of leptin signaling in FI and thermogenesis regulation in pups and adults, we examined the mRNA levels of related genes in the hypothalamus and BAT (Figure 2). Particularly, we examined the expression of genes encoding orexigenic peptides, such as AgRP and NPY, and anorexigenic peptides, such as CART and POMC. Agrp and Npy expression levels in db/db mice at 8 weeks of age were significantly higher than those in WT mice. In contrast, db/db mice at 8 weeks of age displayed significantly lower Cart and Pomc expression in the hypothalamus compared with WT mice. Interestingly, there were no significant differences in Agrp, Npy, Cart, or Pomc expression between WT and db/db mice at 2 weeks of age. As displayed in Figure 2, Ucp1 gene expression in BAT was significantly lower in db/db mice than in WT mice at both ages. Furthermore, expression of the gene encoding peroxisome proliferator-activated receptor gamma, Ppar[gamma], in BAT was significantly lower in db/db mice than that in WT mice at 2 weeks of age but was similar at 8 weeks of age.

4. Discussion

The present study revealed the distinct roles of Lepr in FI and BT regulation in pups and adults using an established mouse line carrying db (a mutation in the gene encoding the leptin receptor long form) without misty (a mutation in the gene encoding Dock7, related to neural development). Regarding the main clinical manifestations such as BW, milk and food intake, and BT, although there may be a slight difference in degree, mice of both sexes displayed a similar tendency of the manifestations. Therefore, further examinations (organ weight, blood chemistry, and gene expression) were performed in males only.

A method using mismatched primers for db genotyping was reported [28, 29]. A novel method for db gene was used to establish a pure db mouse line. This system using a novel restriction enzyme that recognizes the mutated sequence might be easier and more reliable than previous systems (Supplementary Figure 1(a)). This method worked well, leading to the generation of a db mouse line lacking the misty mutation. The length between the Lepr and Dock7 genes is 1.36 cM (chromosome: 4; NC_000070.6; Gene ID 16847 and ID 67299 are designated by NCBI, respectively). Therefore, recombination of the genes is likely in more than 1 out of 50 births [31]. As expected by natural recombination, we ultimately obtained M db/M+, and then a mouse line carrying db without the Dock7 mutation was established (Table 1). In addition, littermates from the line were genotyped as homozygous db and homozygous wild-type Lepr 1 week after birth. BW changes and FI were examined (Figure 1 and Table 2). db/db mice displayed a higher BW after the weaning period but not in pups. Correspondingly, adult, but not pup, db/db mice displayed higher FI. The BW was not significantly different between WT and db/db mice at 2 weeks of age, and the brain, liver, and WAT weights were similar in db/db mice and WT mice. These data suggest that there is a similar role for Lepr signaling between BW regulation and adiposity regulation.

In contrast, db/db mice had lower BT in pups and adults. The results were consistent with those in Zucker rats with a leptin receptor mutation. Zucker rats displayed a lower core BT at 1 week after birth and increased FI later in life [32]. ob mice with leptin deficiency displayed thermogenic defects and similar milk intake, compared with control mice, at around 2 weeks of age, the preobese phase [15, 18].

The findings of the present study regarding FI and BT regulation were corroborated by the results on gene expressions of the hypothalamus and BAT. These findings were consistent with the expression of orexigenic and anorexigenic peptide genes in the hypothalamus and Ucp1 in BAT (Figure 2). In pups, milk intake regulation may not be involved by leptin action because orexigenic and anorexigenic hypothalamic neuropeptide gene expression was not altered in WT and db/db mice. This finding was consistent with reports based on leptin administration experiments including an ob/ob mouse study [20, 33]. Because exogenous leptin administration and the leptin-deficient state displayed no alterations in orexigenic and anorexigenic peptide gene expression in the hypothalamus, leptin signaling, including Lepr, may not regulate FI in pups [20, 33]. After weaning, at 8 weeks of age, orexigenic and anorexigenic peptide genes in the hypothalamus may be altered, in association with higher BW and increased FI in the present study (Figures 1 and 2). The lack of leptin signaling in pups may be explained by the suppression of Lepr gene expression. Alternatively, the leptin signaling cascade from Lepr may be blunted. The mechanisms underlying this regulation such as the methylation state of gene promoters involved in leptin signaling should be examined [34-36].

In contrast, BT was lower in pup and adult db/db mice with long form Lepr deficiency, suggesting that Lepr, particularly the long form, is consistently involved in BT regulation. In adult mice, POMC is important for BT regulation by mediating leptin action [1, 3, 37]. POMC produces melanocyte-stimulating hormone, leading to activation of the melanocortin-4 receptor. Consequently, sympathetic tone is activated. However, in infants, in contrast to adults, Pomc expression levels were similar in db/db mice, suggesting that the decrease in BT is not explained by the reduced signaling of melanocortin-4 receptor involved in POMC (Figure 2(a4)). Reduced BT in db/db mice indicates that Lepr is involved in BT regulation in association with the lower expression of UCP1 at both age, but the precise underlying mechanism has not been elucidated (Figure 2(b1)). This gene expression result may be accordant with BAT weight result of WT and db/db mice, where there was a significant difference between the genotypes under less significant interaction of age and genotype (Table 2). Postnatal db/db mice had a significantly lower expression of PPAR[gamma] (Figure 2(b2)). This finding indicates that decreased BT in db/db mice may underlie the different mechanism between pups and adults [37, 38]. For example, instead of central regulation through sympathetic tone, Lepr expressed in BAT may be involved in heat production through expression of the Ucp1 and Ppar[gamma] genes [39, 40]. In addition, BT is maintained by thyroid function [41]. In the present study, thyroid function was examined. db/db mice displayed lower T4 but similar TSH levels in both ages, suggesting that central hypothyroidism is involved in the reduced BT.

The leptin surge or increased leptin in the postnatal rodents was reported, but its physiological importance remains unclear [18, 19]. The postnatal surge in leptin may set in motion a number of developmental events which do not materialize until later. The increased leptin may be involved in the maintenance of BT in pups through Lepr, partly, associated with thyroid function. Although the mechanism underlying reduced BAT Ucp1 expression in postnatal db/db mice is unclear, it may be related to the lower BT in these mice. Based on our results, the leptin surge may be more involved in BT regulation than in FI regulation.

To the best of our knowledge, the present study is the first to compare db/db and +/+ mice with the BKS background without misty. In the other studies using the db/db mouse line with the BKS background, which is relatively prone to diabetes [21], m/m or m/+ mice were used as controls [42, 43]. The misty mutation may influence BW and findings related to sympathetic nerve activity. To compare the results from the present study, especially, in adult mice with that of other studies with mice harboring the misty mutation, we should consider the results from the control mice, which may be influenced by misty.

In conclusion, the age-dependent phenotypes were corroborated by the results of gene expressions of the hypothalamus and BAT, which have not been fully elucidated in fa rats and ob mice, especially in the preobese phase corresponding to 2 weeks of age. Using a db mouse line without the misty mutation, the different appearances of FI and BT at different ages were presented at the molecular levels, suggesting the age-dependent involvements of the leptin receptor long form in FI and BT.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.


Wijang Pralampita Pulong's present address is Faculty of Medicine, Jember University, Jember 68121, Indonesia.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors' Contributions

Wijang Pralampita Pulong and Miharu Ushikai contributed equally to this work.


We thank Maiko Kawaguchi for administrative assistance. We thank all staff members of the Division of Laboratory Animal Sciences, Natural Science Center for Research and Education, Kagoshima University, who maintained the animals. This research was partly supported by the Kodama Memorial Fund for Medical Research (Miharu Ushikai). We also thank Edanz Group Ltd. for copyediting services.

Supplementary Materials

Supplementary data include sequences of primer for genetic diagnosis and real-time PCR as a table and genotyping of leptin receptor (Lepr) and dedicator of cytokinesis 7 (Dock7) genes related to db and misty as a figure. (Supplementary Materials)


[1] J. M. Friedman and J. L. Halaas, "Leptin and the regulation of body weight in mammals," Nature, vol. 395, no. 6704, pp. 763-770, 1998.

[2] I. S. Farooqi, T. Wangensteen, S. Collins et al., "Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor," The New England Journal of Medicine, vol. 356, no. 3, pp. 237-247, 2007.

[3] M. B. Allison and M. G. Myers Jr, "20 years of leptin: connecting leptin signaling to biological function," The Journal of Endocrinology, vol. 223, no. 1, pp. T25-T35, 2014.

[4] D. M. Muoio and G. Lynis Dohm, "Peripheral metabolic actions of leptin," Best Practice & Research Clinical Endocrinology & Metabolism, vol. 16, no. 4, pp. 653-666, 2002.

[5] L. Zabeau, D. Defeau, J. Van der Heyden, H. Iserentant, J. Vandekerckhove, and J. Tavernier, "Functional analysis of leptin receptor activation using a Janus kinase/signal transducer and activator of transcription complementation assay," Molecular Endocrinology, vol. 18, no. 1, pp. 150-161, 2004.

[6] P. J. Enriori, P. Sinnayah, S. E. Simonds, C. Garcia Rudaz, and M. A. Cowley, "Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance," The Journal of Neuroscience, vol. 31, no. 34, pp. 12189-12197, 2011.

[7] N. Ottaway, P. Mahbod, B. Rivero et al., "Diet-induced obese mice retain endogenous leptin action," Cell Metabolism, vol. 21, no. 6, pp. 877-882, 2015.

[8] R. S. Ahima, C. Bjorbaek, S. Osei, and J. S. Flier, "Regulation of neuronal and glial proteins by leptin: implications for brain development," Endocrinology, vol. 140, no. 6, pp. 2755-2762, 1999.

[9] E. Caron, C. Sachot, V. Prevot, and S. G. Bouret, "Distribution of leptin-sensitive cells in the postnatal and adult mouse brain," The Journal of Comparative Neurology, vol. 518, no. 4, pp. 459-476, 2010.

[10] B. Wang, P. Chandrasekera, and J. Pippin, "Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes," Current Diabetes Reviews, vol. 10, no. 2, pp. 131-145, 2014.

[11] T. M. Mizuno, S. P. Kleopoulos, H. T. Bergen, J. L. Roberts, C. A. Priest, and C. V. Mobbs, "Hypothalamic proopiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin," Diabetes, vol. 47, no. 2, pp. 294-297, 1998.

[12] C. de Luca, T. J. Kowalski, Y. Zhang et al., "Complete rescue of obesity, diabetes, and infertility in db/db mice by neuronspecific LEPR-B transgenes," The Journal of Clinical Investigation, vol. 115, no. 12, pp. 3484-3493, 2005.

[13] M. E. Hall, M. W. Maready, J. E. Hall, and D. E. Stec, "Rescue of cardiac leptin receptors in db/db mice prevents myocardial triglyceride accumulation," American Journal of Physiology, Endocrinology and Metabolism, vol. 307, no. 3, pp. E316-E325, 2014.

[14] J.-N. Huan, J. Li, Y. Han, K. Chen, N. Wu, and A. Z. Zhao, "Adipocyte-selective reduction of the leptin receptors induced by antisense RNA leads to increased adiposity, dyslipidemia, and insulin resistance," The Journal of Biological Chemistry, vol. 278, no. 46, pp. 45638-45650, 2003.

[15] P.-Y. Lin, D. R. Romsos, and G. A. Leveille, "Food intake, body weight gain, and body composition of the young obese (ob/ob) mouse," The Journal of Nutrition, vol. 107, no. 9, pp. 1715-1723, 1977.

[16] E. Ioffe, B. Moon, E. Connolly, and J. M. Friedman, "Abnormal regulation of the leptin gene in the pathogenesis of obesity," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 20, pp. 11852-11857, 1998.

[17] H.-M. Choi, H. R. Kim, E.-K. Kim et al., "An age-dependent alteration of the respiratory exchange ratio in the db/db mouse," Laboratory Animal Research, vol. 31, no. 1, pp. 1-6, 2015.

[18] P. Trayhurn, P. L. Thurlby, and W. P. T. James, "Thermogenic defect in pre-obese ob/ob mice," Nature, vol. 266, no. 5597, pp. 60-62, 1977.

[19] R. S. Ahima and S. M. Hileman, "Postnatal regulation of hypothalamic neuropeptide expression by leptin: implications for energy balance and body weight regulation," Regulatory Peptides, vol. 92, no. 1-3, pp. 1-7, 2000.

[20] R. S. Ahima, D. Prabakaran, and J. S. Flier, "Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function," The Journal of Clinical Investigation, vol. 101, no. 5, pp. 1020-1027, 1998.

[21] R. C. Davis, L. W. Castellani, M. Hosseini et al., "Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS-db/db mice," Diabetes, vol. 59, no. 7, pp. 1616-1625, 2010.

[22] D. L. Coleman, "Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice," Diabetologia, vol. 14, no. 3, pp. 141-148, 1978.

[23] G. E. Truett, R. J. Tempelman, J. A. Walker, and J. K. Wilson, "Misty (m) affects growth traits," American Journal of Physiology, vol. 275, no. 1, pp. R29-R32, 1998.

[24] E. V. Sviderskaya, E. K. Novak, R. T. Swank, and D. C. Bennett, "The murine misty mutation: phenotypic effects on melanocytes, platelets and brown fat," Genetics, vol. 148, no. 1, pp. 381-390, 1998.

[25] M. Watabe-Uchida, K. A. John, J. A. Janas, S. E. Newey, and L. Van Aelst, "The Rac activator DOCK7 regulates neuronal polarity through local phosphorylation of stathmin/Op18," Neuron, vol. 51, no. 6, pp. 727-739, 2006.

[26] K. J. Motyl, K. A. Bishop, V. E. DeMambro et al., "Altered thermogenesis and impaired bone remodeling in misty mice," Journal of Bone and Mineral Research, vol. 28, no. 9, pp. 1885-1897, 2013.

[27] T. Sakoguchi, M. Horiuchi, A. Asakawa et al., "Failure of the feeding response to fasting in carnitine-deficient juvenile visceral steatosis (JVS) mice: involvement of defective acylghrelin secretion and enhanced corticotropin-releasing factor signaling in the hypothalamus," Biochimica et Biophysica Acta, vol. 1792, no. 11, pp. 1087-1093, 2009.

[28] F. R. DeRubertis, P. A. Craven, M. F. Melhem, and E. M. Salah, "Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction," Diabetes, vol. 53, no. 3, pp. 762-768, 2004.

[29] M. Jimenez-Palomares, J. J. Ramos-Rodriguez, J. F. Lopez-Acosta et al., "Increased A[beta] production prompts the onset of glucose intolerance and insulin resistance," American Journal of Physiology-Endocrinology and Metabolism, vol. 302, no. 11, pp. E1373-E1380, 2012.

[30] L. M. Wilson, M. L. Stewart, and E. P. McAnanama, "Milk intakes of genetically obese (ob/b) and lean mouse pups differ with enhanced milk supply," Physiology and Behavior, vol. 46, no. 5, pp. 823-827, 1989.

[31] A. Cox, C. L. Ackert-Bicknell, B. L. Dumont et al., "A new standard genetic map for the laboratory mouse," Genetics, vol. 182, no. 4, pp. 1335-1344, 2009.

[32] S. Krief and R. Bazin, "Genetic obesity: is the defect in the sympathetic nervous system? A review through developmental studies in the preobese Zucker rat," Proceedings of the Society for Experimental Biology and Medicine, vol. 198, no. 1, pp. 528-538, 1991.

[33] A. M. Mistry, A. Swick, and D. R. Romsos, "Leptin alters metabolic rates before acquisition of its anorectic effect in developing neonatal mice," American Journal of Physiology, vol. 277, no. 3, pp. R742-R747, 1999.

[34] S. A. Benite-Ribeiro, D. A. Putt, M. C. Soares-Filho, and J. M. Santos, "The link between hypothalamic epigenetic modifications and long-term feeding control," Appetite, vol. 107, pp. 445-453, 2016.

[35] Y. Wu, A. V. Patchev, G. Daniel, O. F. X. Almeida, and D. Spengler, "Early-life stress reduces DNA methylation of the Pomc gene in male mice," Endocrinology, vol. 155, no. 5, pp. 1751-1762, 2014.

[36] S. Forbes, S. Bui, B. R. Robinson, U. Hochgeschwender, and M. B. Brennan, "Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 4233-4237, 2001.

[37] T. Imai, R. Takakuwa, S. Marchand et al., "Peroxisome proliferator-activated receptor [gamma] is required in mature white and brown adipocytes for their survival in the mouse," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 13, pp. 4543-4547, 2004.

[38] R. Gao, W. Chen, H. Yan et al., "PPAR[gamma] agonist rosiglitazone switches fuel preference to lipids in promoting thermogenesis under cold exposure in C57BL/6 mice," Journal of Proteomics, vol. 176, pp. 24-36, 2018.

[39] C. A. Siegrist-Kaiser, V. Pauli, C. E. Juge-Aubry et al., "Direct effects of leptin on brown and white adipose tissue," The Journal of Clinical Investigation, vol. 100, no. 11, pp. 2858-2864, 1997.

[40] G. Fruhbeck, J. Gomez-Ambrosi, and J. A. Martinez, "Pre- and postprandial expression of the leptin receptor splice variants OB-Ra and OB-Rb in murine peripheral tissues," Physiological Research, vol. 48, no. 3, pp. 189-195, 1999.

[41] M. Korbonits, "Leptin and the thyroid - a puzzle with missing pieces," Clinical Endocrinology, vol. 49, no. 5, pp. 569-572, 1998.

[42] J. S. Noh, H. Y. Kim, C. H. Park, H. Fujii, and T. Yokozawa, "Hypolipidaemic and antioxidative effects of oligonol, a low-molecular-weight polyphenol derived from lychee fruit, on renal damage in type 2 diabetic mice," British Journal of Nutrition, vol. 104, no. 8, pp. 1120-1128, 2010.

[43] S. Chen, F. Okahara, N. Osaki, and A. Shimotoyodome, "Increased GIP signaling induces adipose inflammation via a HIF-1[alpha]-dependent pathway and impairs insulin sensitivity in mice," American Journal of Physiology. Endocrinology and Metabolism, vol. 308, no. 5, pp. E414-E425, 2015.

Wijang Pralampita Pulong, (1) Miharu Ushikai, (1) Emi Arimura, (1,2) Masaharu Abe, (1) Hiroaki Kawaguchi, (1) and Masahisa Horiuchi [ID] (1)

(1) Department of Hygiene and Health Promotion Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima City, Kagoshima 890-8544, Japan

(2) Department of Life and Environmental Science, Kagoshima Prefectural College, Kagoshima City, Kagoshima 890-0005, Japan

Correspondence should be addressed to Masahisa Horiuchi;

Received 30 May 2018; Accepted 22 October 2018; Published 3 December 2018

Academic Editor: Jonathan M. Peterson

Caption: Figure 1: Body weight (BW) change during development. Weekly BWs of male (a) and female mice (b) are displayed. Open symbols represent WT (+/+) mice, and closed symbols represent db/db mice. The sample size of all groups is 6. The values are the mean [+ or -] SE. The data were analyzed statistically by two-way (repeated measurement) ANOVA. ** P < 0.01 compared with WT mice. NS: not significant.

Caption: Figure 2: Expression of genes related to food intake and thermogenesis regulation in the hypothalamus and brown adipose tissue (BAT). Expression of genes in the hypothalamus are shown (a). Agrp (a1), Npy (a2), Cart (a3), and Pomc (a4) expression levels are displayed relative to Gapdh mRNA levels. Expression of genes related to thermogenesis in BAT (b). Ucp1 (b1) and Ppar[gamma] (b2) mRNA levels are displayed relative to Gapdh mRNA levels. The sample size of all groups is 7-8. The values are the mean + SE. The values are expressed as the fold change relative to WT mice at the respective age (all values were set to 1.0). Open columns and closed columns represent WT (+/+) mice and db/db mice, respectively. The data were analyzed statistically by unpaired Student's t-test. * P < 0.05, ** P < 0.01 compared with WT mice at the respective age.
Table 1: DNA diagnosis of mice purchased from companies.


                           A            B
Coat color/            Black/lean   Black/lean
body appearance
                    Expected genotype
Gene 1/gene 2           M db/m+      M db/m+

Experimental results
M db/m+, M+/m db       10 (83.3)    19 (95.0)
M db/M+                 2 (16.7)     1 (5.0)
M+/m db                  0 (0)        0 (0)
M+/m+                    0 (0)        0 (0)
M+/M+                    0 (0)        0 (0)

Genes 1 and 2 are shown as a pair of genotypes of dedicator
of cytokinesis 7 (Dock7) gene and leptin receptor (Lepr)
gene. M: wild type of Dock7; m: a mutation type (misty) of
Dock7; +: wild type of Lepr; db: a mutation type of Lepr.
The number of mice diagnosed is described. The mice examined
from the company A and company B were 12 and 20, respectively.
The number in parentheses denotes the percentage.

Table 2: Organ weight and biochemical parameters including
hormones at 2 and 8 weeks.

                                          2 weeks

Male                                     WT (N = 8)
Body weight             g          6.15 [+ or -] 0.18 (a)
Milk intake #          g/h          0.146 [+ or -] 0.015
Food intake           g/day
  Brain                 mg        355.0 [+ or -] 5.6 (ab)
  Heart                 mg           34.8 [+ or -] 2.0
  Liver                 g          0.19 [+ or -] 0.01 (a)
  WAT                   g         0.013 [+ or -] 0.002 (a)
  BAT                   mg           61.0 [+ or -] 6.5
  Glucose              g/l         1.12 [+ or -] 0.05 (a)
  TG                   g/l           0.68 [+ or -] 0.10
  Insulin             ng/ml        0.40 [+ or -] 0.03 (a)
  Leptin              ng/ml         4.0 [+ or -] 1.1 (a)
  Corticosterone      ng/ml        43.6 [+ or -] 7.1 (a)
  T3                  ng/ml          2.80 [+ or -] 0.01
  T4                  ng/ml          98.6 [+ or -] 3.5
  TSH              [micro]IU/ml      6.71 [+ or -] 0.47

Female                                   WT (N = 5)
Body weight             g          6.01 [+ or -] 0.11 (a)
Milk intake            g/h          0.093 [+ or -] 0.024
Food intake           g/day

                                          2 weeks

Male                                    db/db (N = 8)
Body weight             g          6.41 [+ or -] 0.21 (a)
Milk intake #          g/h        0.153 [+ or -] 0.024 (NS)
Food intake           g/day
  Brain                 mg         335.5 [+ or -] 5.9 (a)
  Heart                 mg            30.0 [+ or -] 1.1
  Liver                 g          0.19 [+ or -] 0.01 (a)
  WAT                   g         0.026 [+ or -] 0.003 (a)
  BAT                   mg            76.5 [+ or -] 6.3
  Glucose              g/l         1.01 [+ or -] 0.04 (a)
  TG                   g/l           0.79 [+ or -] 0.12
  Insulin             ng/ml        0.59 [+ or -] 0.08 (a)
  Leptin              ng/ml         46.6 [+ or -] 5.4 (b)
  Corticosterone      ng/ml         56.3 [+ or -] 8.7 (a)
  T3                  ng/ml          2.92 [+ or -] 0.14
  T4                  ng/ml           81.5 [+ or -] 5.2
  TSH              [micro]IU/ml      7.06 [+ or -] 0.40

Female                                  db/db (N = 5)
Body weight             g          6.37 [+ or -] 0.14 (a)
Milk intake            g/h        0.102 [+ or -] 0.031 (NS)
Food intake           g/day

                                          8 weeks

Male                                     WT (N = 8)
Body weight             g         24.91 [+ or -] 0.30 (b)
Milk intake #          g/h
Food intake           g/day          3.42 [+ or -] 0.09
  Brain                 mg         421.7 [+ or -] 3.6 (c)
  Heart                 mg           120.9 [+ or -] 1.5
  Liver                 g          1.36 [+ or -] 0.03 (b)
  WAT                   g         0.250 [+ or -] 0.013 (b)
  BAT                   mg           103.2 [+ or -] 8.0
  Glucose              g/l         2.29 [+ or -] 0.19 (a)
  TG                   g/l           1.04 [+ or -] 0.13
  Insulin             ng/ml        0.99 [+ or -] 0.09 (a)
  Leptin              ng/ml         1.1 [+ or -] 0.3 (a)
  Corticosterone      ng/ml       148.0 [+ or -] 33.2 (a)
  T3                  ng/ml          1.16 [+ or -] 0.03
  T4                  ng/ml          41.6 [+ or -] 1.5
  TSH              [micro]IU/ml      0.99 [+ or -] 0.23

Female                                   WT (N = 5)
Body weight             g         19.38 [+ or -] 0.21 (b)
Milk intake            g/h
Food intake           g/day          3.03 [+ or -] 0.09

                                          8 weeks

Male                                   db/db (N = 8)
Body weight             g         41.82 [+ or -] 0.75 (c)
Milk intake #          g/h
Food intake           g/day        7.60 [+ or -] 0.33 **
  Brain                 mg         363.3 [+ or -] 5.1 (b)
  Heart                 mg           117.9 [+ or -] 2.8
  Liver                 g          2.79 [+ or -] 0.11 (c)
  WAT                   g         1.781 [+ or -] 0.073 (c)
  BAT                   mg          198.9 [+ or -] 49.4
  Glucose              g/l         6.14 [+ or -] 0.89 (b)
  TG                   g/l           1.20 [+ or -] 0.17
  Insulin             ng/ml        9.61 [+ or -] 3.53 (b)
  Leptin              ng/ml        94.6 [+ or -] 7.2 (c)
  Corticosterone      ng/ml       292.3 [+ or -] 52.1 (b)
  T3                  ng/ml          1.22 [+ or -] 0.04
  T4                  ng/ml          33.7 [+ or -] 0.9
  TSH              [micro]IU/ml      1.85 [+ or -] 0.75

Female                                 db/db (N = 5)
Body weight             g         39.27 [+ or -] 0.92 (c)
Milk intake            g/h
Food intake           g/day        7.34 [+ or -] 0.43 **

                                       P values (two-way ANOVA)

Male                                Age     Genotype   Interaction
Body weight             g         (<0.01)   (<0.01)       <0.01@
Milk intake #          g/h
Food intake           g/day
  Brain                 mg        (<0.01)   (<0.01)       <0.01@
  Heart                 mg         <0.01     0.055        0.660
  Liver                 g         (<0.01)   (<0.01)       <0.01@
  WAT                   g         (<0.01)   (<0.01)       <0.01@
  BAT                   mg         <0.01     0.037        0.126
  Glucose              g/l        (<0.01)   (<0.01)       <0.01@
  TG                   g/l         <0.01     0.284        0.844
  Insulin             ng/ml       (<0.01)   (<0.019)      0.024@
  Leptin              ng/ml       (<0.01)   (<0.01)       <0.01@
  Corticosterone      ng/ml       (<0.01)   (<0.013)      0.034@
  T3                  ng/ml        <0.01     0.235        0.688
  T4                  ng/ml        <0.01     <0.01        0.172
  TSH              [micro]IU/ml    <0.01     0.236        0.617

Female                              Age     Genotype   Interaction
Body weight             g         (<0.01)   (<0.01)       <0.01@
Milk intake            g/h
Food intake           g/day

WT: wild type (homozygous wild type in leptin receptor gene); db-db:
leptin receptor deficiency (homozygous mutants in leptin receptor
gene); BW: body weight; WAT: white adipose tissue; BAT: brown adipose
tissue; TG: triglyceride; T3: triiodothyronine; T4: thyroxine; TSH:
thyroid-stimulating hormone. # The number of male samples for milk
intake measurement was 7. All data were obtained from mice after 3 h
fasting except milk and food intake (described in detail in Materials
and Methods). Values are the mean [+ or -] SE. Values except milk and
food intake were analyzed by two-way ANOVA (interaction, age, and
genotype) followed by the Tukey-Kramer method when significant. Bold
values mean the significance in the interaction. In the case, the main
effect of age and genotype is shown by the parenthesis as a reference.
Values of milk and food intake were analyzed by unpaired Student's
t-test, respectively. The same superscript letter and NS indicate that
the difference was not significant. ** P < 0.01 vs. WT mice at the
respective age.

Note: The significance in the interaction indicated with @.

Table 3: Core body temperature in light and dark phases at 2 and
8 weeks.

                                        2 weeks

Male                          WT                        db/db
Time                         N = 7                      N = 6
measured (h)

8:00    [degrees]C   35.70 [+ or -] 0.22        33.93 [+ or -] 0.20
20:00   [degrees]C   36.38 [+ or -] 0.18 (NS)   34.99 [+ or -] 0.21 *

Female                        WT                        db/db
Time                         N = 5                      N = 5
measured (h)

8:00    [degrees]C   36.14 [+ or -] 0.09        33.89 [+ or -] 0.15
20:00   [degrees]C   37.36 [+ or -] 0.11 **     34.96 [+ or -] 0.15 **

                                       8 weeks

Male                          WT                     db/db
Time                         N = 5                   N = 5
measured (h)

8:00    [degrees]C   36.66 [+ or -] 0.21     34.51 [+ or -] 0.34
20:00   [degrees]C   38.10 [+ or -] 0.28 *   36.60 [+ or -] 0.15 **

Female                        WT                     db/db
Time                         N = 5                   N = 5
measured (h)

8:00    [degrees]C   36.64 [+ or -] 0.13     33.96 [+ or -] 0.13
20:00   [degrees]C   37.90 [+ or -] 0.10 **  35.89 [+ or -] 0.28 **

                        P values (two-way ANOVA)

Time                  Age    Genotype   Interaction
measured (h)

8:00    [degrees]C   <0.01    <0.01        0.455
20:00   [degrees]C   <0.01    <0.01        0.795

Time                  Age    Genotype   Interaction
measured (h)

8:00    [degrees]C   0.051    <0.01        0.126
20:00   [degrees]C   <0.01    <0.01        0.279

WT: wild type (homozygous wild type in Lepr gene); db/db: leptin
receptor deficiency (homozygous mutants in Lepr gene). Values are the
mean [+ or -] SE. Values were analyzed by two-way ANOVA (interaction,
age, and genotype). Values of the respective genotype male or female
mice at the same age were analyzed by paired Student's t-test.
(NS): not significant; * P < 0.05, ** P < 0.01 vs. male or female mice
of the respective genotype at the same age at 8:00 h.
COPYRIGHT 2018 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Pulong, Wijang Pralampita; Ushikai, Miharu; Arimura, Emi; Abe, Masaharu; Kawaguchi, Hiroaki; Horiuch
Publication:Journal of Diabetes Research
Date:Jan 1, 2018
Previous Article:Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy.
Next Article:In the View of Endothelial Microparticles: Novel Perspectives for Diagnostic and Pharmacological Management of Cardiovascular Risk during Diabetes...

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters